Amyris initiates strategic transformation program and secures funding

Emeryville, calif. , june 5, 2023 /prnewswire/ -- amyris, inc. (nasdaq: amrs), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its lab-to-markettm technology platform and clean beauty consumer brands, today announced that its board of directors has engaged the business recovery services unit of pricewaterhousecoopers ("pwc") and established a subcommittee of the board (the "restructuring committee"), made up of three independent directors, working with management, to execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity.
AMRS Ratings Summary
AMRS Quant Ranking